#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / General Practitioner / 2023 - 5

Health effects of coffee

Czech version

Authors: K. Bezděk
Published in: Prakt. Lék. 2023; 103(5): 219-224
Category: Reviews

Overview

Coffee is a very popular drink used as a stimulant, but also socially when meeting people or traditionally at the end of the eating menu. It is a brewed drink prepared from roasted seeds of a bush of the genus Coffea. In addition to the alkaloid caffeine, it contains a number of unique components that are responsible for various health effects. In the 1970s, data began to emerge on the increased risk of cancer and cardiovascular disease associated with coffee consumption. However, these were population-based studies in which coffee drinking was associated with other social behaviours (notably cigarette smoking) and causality could not be proven. In contrast, the better quality studies of the new millennium point to possible multiple health benefits of coffee drinking. Probably the highest assumption of health benefits can be achieved by consuming 3–4 cups of this beverage. Such a quantity of coffee does not contain sufficient caffeine to cause a significant diuretic effect.

Sources
  1. Statista. Coffee production worldwide from 2003/04 to 2020/21 (in million 60 kilogram bags) [online]. Dostupné z: https://www. statista.com/statistics/263311/worldwide-production-of-coffee/ [cit. 2023-02-27].
  2. Luttinger N, Dicum G. The Coffee Book: Anatomy of an industry from the crop to the last drop. New York: The New Press 1999.
  3. Clifford MN. Chlorogenic acids and other cinnamates – nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric 2000; 80(7): 1033–1043.
  4. Ludwig IA, Clifford MN, Lean MEJ, et al. Coffee: biochemistry and potential impact on health. Food Funct 2014; 5(8): 1695– 1717.
  5. Liang N, Kitts DD. Antioxidant property of coffee components: assessment of methods that define mechanisms of action. Molecules 2014; 19(11): 19180–19208.
  6. Corrêa TAF, Monteiro MP, Mendes TMN, et al. Medium light and medium roast paper-filtered coffee increased antioxidant capacity in healthy volunteers: results of a randomized trial. Plant Foods Hum Nutr 2012; 67: 277–282.
  7. Jaquet M, Rochat I, Moulin J, et al. Impact of coffee consumption on the gut microbiota: a human volunteer study. Int J Food Microbiol 2009; 130(2): 117–121.
  8. Vitaglione P, Morisco F, Mazzone G, et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010; 52(5): 1652–1561.
  9. Lecoultre V, Carrel G, Egli L, et al. Coffee consumption attenuates shortterm fructose-induced liver insulin resistence in healthy men. Am J Clin Nutr 2014; 99(2): 268–275.
  10. Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu Rev Nutr 1997; 17: 305–324.
  11. Nathanson JA. Caffeine and related methylxanthines: possible naturally occurring pesticides. Science 1984; 226(4671): 184–187.
  12. Fredholm BB, Bättig K, Holmén J, et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999; 51(1): 83–133.
  13. U.S. Department of Agriculture. Food Data Central [online]. Dostupné z: https://fdc.nal.usda.gov/ [cit. 2023-02-27].
  14. Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007; 357(19): 1893–1902.
  15. Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev 2018; 70(2): 384–411.
  16. Schwarzschild MA, Xu K, Oztas E, et al. Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinsonʼs disease. Neurology 2003; 61(11 Suppl 6): S55–S61.
  17. U.S. Food and Drug Administration. Guidance for industry: Highly concentrated caffeine in dietary supplements, April 2018 [online]. Dostupné z: https://www.fda.gov/media/112363/download [cit. 2023-02-27].
  18. Ehlers A, Marakis G, Lampen A, Hirsch-Ernst KI. Risk assessment of energy drinks with focus on cardiovascular parameters and energy drink consumption in Europe. Food Chem Toxicol 2019; 130: 109–121.
  19. Loftfield E, Cornelis MC, Caporaso N, et al. Association of coffee drinking with mortality by genetic variation in caffeine metabolism: findings from the UK Biobank. JAMA Intern Med 2018; 178(8): 1086–1097.
  20. Freedman ND, Park Y, Abnet CC, et al. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012; 366: 1891–1904.
  21. Tamakoshi A, Lin Y, Kawado M, et al. Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study. Eur J Epidemiol 2011; 26(4): 285–293.
  22. Park SY, Freedman ND, Haiman CA, et al. Association of coffee consumption with total and cause-specific mortality among nonwhite populations. Ann Intern Med 2017; 167(4): 228–235.
  23. Huxley R, Lee CM, Barzi F, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 2009; 169(22): 2053–2063.
  24. Bhupathiraju SN, Pan A, Manson JE, et al. Changes in coffee intake and subsequent risk of type 2 diabetes: three large cohorts of US men and women. Diabetologia 2014; 57(7): 1346–1354.
  25. Sartorelli DS, Fagherazzi G, Balkau B, et al. Differential effects of coffee on the risk of type 2 diabetes according to meal consumption in a French cohort of women: the E3N/EPIC cohort study. Am J Clin Nutr 2010; 91(4): 1002–1012.
  26. Shi L, Brunius C, Johansson I, et al. Plasma metabolite biomarkers of boiled and filtered coffee intake and their association with type 2 diabetes risk. J Intern Med 2020; 287(4): 405–421.
  27. Loopstra-Masters RC, Liese AD, Haffner SM, et al. Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function. Diabetologia 2011; 54(2): 320–328.
  28. Yarmolinsky J, Mueller NT, Duncan BB, et al. Coffee consumption, newly diagnosed diabetes, and other alterations in Ggucose homeostasis: A cross-sectional analysis of the longitudinal study of adult health (ELSA-Brasil). PLoS One 2015; 10: e0126469.
  29. Fujii Y, Osaki N, Hase T, Shimotoyodome A. Ingestion of coffee polyphenols increases postprandial release of the active glucagon-like peptide-1 (GLP1(7–36)) amide in C57BL/6J mice. J Nutr Sci 2015; 4: e9.
  30. Rustenbeck I, Lier-Glaubitz V, Willenborg M, et al. Effect of chronic coffee consumption on weight gain and glycaemia in a mouse model of obesity and type 2 diabetes. Nutr Diabetes 2014; 4: e123.
  31. Jacobson K, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 2006; 5(3): 247–264.
  32. Zhao Y, Wang J, Ballevre O, et al. Antihypertensive effects and mechanisms of chlorogenic acids. Hypertens Res 2012; 35(4): 370–374.
  33. Ding M, Bhupathiraju SN, Satija A, et al. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 2014; 129(6): 643–659.
  34. Wu JN, Ho SC, Zhou C, et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol 2009; 137(3): 216–225.
  35. Mostofsky E, Rice MS, Levitan EB, et al. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circ Heart Fail 2012; 5(4): 401–405.
  36. Cheng M, Hu Z, Lu X, et al. Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies. Can J Cardiol 2014; 30(4): 448–454.
  37. Steffen M, Kuhle C, Hensrud D, et al. The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens 2012; 30(12): 2245–2254.
  38. Grosso G, Micek A, Godos J, et al. Long-term coffee consumption is associated with decreased incidence of new-onset hypertension: a dose-response meta-analysis. Nutrients. 2017; 9(8): 890.
  39. Natella F, Nardini M, Belelli F, Scaccini C. Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans. Am J Clin Nutr 2007; 86(3): 604–609.
  40. Montagnana M, Favaloro E. Coffee intake and cardiovascular disease: virtue does not take center stage. Semin Thromb Hemost 2012; 38(2): 164–177.
  41. Cornelis M, Gustafsson S, Ärnlöv J, et al. Targeted proteomic analysis of habitual coffee consumption. J Intern Med 2018; 283(2): 200–211.
  42. Jee SH, He J, Appel LJ, et al. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2001; 153(4): 353–362.
  43. Silverman MG, Ference BA, Im K, et al. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA 2016; 316(12): 1289–1297.
  44. Larsson S, Orsini N. Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol 2011; 174(9): 993–1001.
  45. Shao C, Tang H, Wang X, He J. Coffee consumption and stroke risk: evidence from a systematic review and meta-analysis of more than 2.4 million men and women. J Stroke Cerebrovasc Dis 2021; 30(1): 105452.
  46. Zhao LG, Li ZY, Feng GS, et al. Coffee drinking and cancer risk: an umbrella review of meta-analyses of observational studies. BMC Cancer 2020; 20(1): 101.
  47. Bravi F, Tavani A, Bosetti C, et al. Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies. Eur J Cancer Prev 2017; 26(5): 368–377.
  48. Li J, Seibold P, Chang-Claude J, et al. Coffee consumption modifies risk of estrogen-receptor negative breast cancer. Breast Cancer Res 2011; 13(3): R49.
  49. Lafranconi A, Micek A, De Paoli P, et al. Coffee intake decreases risk of postmenopausal breast cancer: a dose-response meta-analysis on prospective cohort studies. Nutrients 2018; 10(2): 112.
  50. Micek A, Godos J, Lafranconi A, et al. Caffeinated and decaffeinated coffee consumption and melanoma risk: a dose-response meta-analysis of prospective cohort studies. Int J Food Sci Nutr 2018; 69(4): 417–426.
  51. Song F, Qureshi A, Han J. Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin. Cancer Res 2012; 72(13): 3282–3289.
  52. Galeone C, Tavani A, Pelucchi C, et al. Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2010; 19(7): 1723–1736.
  53. Schmit SL, Rennert HS, Rennert G, Gruber SB. Coffee consumption and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2016; 25(4): 634–639.
  54. Wilson K, Kasperzyk J, Rider JR, et al. Coffee consumption and prostate cancer risk and progression in the health professionals follow-up study. J Natl Cancer Inst 2011; 103(11): 876–884.
  55. Xia J, Chen J, Xue JX, et al. An up-to-date meta-analysis of coffee consumption and risk of prostate cancer. Urol J 2017; 14(5): 4079–4088.
  56. Parodi S, Merlo FD, Stagnaro E; working group for the epidemiology of hematolymphopoietic malignancies in Italy. Coffee consumption and risk of non-Hodgkin’s lymphoma: evidence from the Italian multicentre case-control study. Cancer Causes Control 2017; 28(8): 867–876.
  57. Wu W, Tong Y, Zhao Q, et al. Coffee consumption and bladder cancer: a meta-analysis of observational studies. Sci Rep 2015; 5: 9051.
  58. Magalhães R, Picó-Pérez M, Esteves M, et al. Habitual coffee drinkers display a distinct pattern of brain functional connectivity. Mol Psychiatry 2021; 26(11): 6589–6598.
  59. Cornelis MC, Weintraub S, Morris MC. Caffeinated coffee and tea consumption, genetic variation and cognitive function in the UK Biobank. J Nutr 2020; 150(8): 2164–2174.
  60. Kang D, Kim Y, Je Y. Non-alcoholic beverage consumption and risk of depression: epidemiological evidence from observational studies. Eur J Clin Nutr 2018; 72(11): 1506–1516.
  61. Lucas M, O’Reilly EJ, et al. Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults. World J Biol Psychiatry 2014; 15(5): 377–386.
  62. Cao C, Loewenstein D, Lin X, et al. High blood caffeine levels in MCI linked to lack of progression to dementia. J Alzheimers Dis 2012; 30(3): 559–572.
  63. Larsson SC, Orsini N. Coffee consumption and risk of dementia and Alzheimer’s disease: a dose-response metaanalysis of prospective studies. Nutrients 2018; 10(10): 1501.
  64. Poole R, Kennedy OJ, Roderick P, et al. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ 2017; 359: j5024.
  65. Ross W, Duda J, Abbott R, et al. Association of coffee and caffeine consumption with brain Lewy Pathology in the HonoluluAsia aging study. Neurology 2012; 78(1 Suppl): S42.005.
  66. Xu K, Di Luca DG, Orrú M, et al. Neuroprotection by caffeine in the MPTP model of Parkinson’s disease and its dependence on adenosine A2A receptors. Neuroscience 2016; 322: 129–137.
  67. Nehlig A, Daval JL. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 1992; 17(2): 139–170.
  68. Dong X, Li S, Sun J, et al. Association of coffee, decaffeinated coffee and caffeine intake from coffee with cognitive performance in older adults: National Health and Nutrition Examination Survey (NHANES) 2011–2014. Nutrients 2020; 12(3):840.
  69. Pham K, Mulugeta A, Zhou A, et al. High coffee consumption, brain volume and risk of dementia and stroke. Nutr Neurosci 2022; 25(10): 2111–2122.
  70. Kennedy OJ, Roderick P, Buchanan R, et al. Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Aliment Pharmacol Ther 2016; 43(5): 562–574.
  71. Wijarnpreecha K, Thongprayoon C, Ungprasert P. Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2017; 29(2): e8–e12.
  72. Freedman ND, Everhart JE, Lindsay KL, et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 2009; 50(5): 1360–1369.
  73. van Dam RM, Hu FB, Willett WC. Coffee, caffeine, and health. N Engl J Med 2020; 383(4): 369–378.
  74. Boekema PJ, van Dam van Isselt EF, Bots ML, Smout AJ. Functional bowel symptoms in a general Dutch population and associations with common stimulants. Neth J Med 2001; 59(1): 23–30.
  75. Kim J, Oh SW, Myung SK, et al. Korean Metaanalysis (KORMA) Study Group. Association between coffee intake and gastroesophageal reflux disease: a meta-analysis. Dis Esophagus 2013; 27(4): 311–317.
  76. Shimamoto T, Yamamichi N, Kodashima S, et al. No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan. PLoS One 2013; 86: e65996.
  77. Loomis D, Guyton KZ, Grosse Y, et al. International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol 2016; 17(7): 877–878.
  78. Botelho F, Lunet N, Barros H. Coffee and gastric cancer: systematic review and meta-analysis. Cad Saude Publica 2006; 22(5): 889–900.
  79. Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2015; 64(7): 1063–1071.
  80. Andersen LF, Jacobs DR jr., Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 2006; 83(5): 1039–1046.
  81. Brown AC, Rampertab SD, Mullin GE. Existing dietary guidelines for Crohn's disease and ulcerative colitis. Expert Rev Gastroenterol Hepatol 2011; 5(3): 411–425.
  82. Zhang Y-P, Li W-Q, Sun YL, et al. Systematic review with metaanalysis: coffee consumption and the risk of gallstone disease. Aliment Pharmacol Ther 2015; 42(6): 637–648.
  83. Harpaz E, Tamir S, Weinstein A, Weinstein Y. The effect of caffeine on energy balance. J Basic Clin Physiol Pharmacol 2017; 28(1): 1–10.
  84. Velickovic K, Wayne D, Leija, HAL, et al. Caffeine exposure induces browning features in adipose tissue in vitro and in vivo. Sci Rep 2019; 9: 9104.
  85. Dulloo AG, Geissler CA, Horton T, et al. Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr 1989; 49(1): 44–50.
  86. Jeszka-Skowron M, Zgoła-Grześkowiak A, Grześkowiak T. Analytical methods applied for the characterization and the determination of bioactive compounds in coffee. Eur Food Res Technol 2015; 240: 19–31.
  87. Jiwani AZ, Rhee DJ, Brauner SC, et al. Effects of caffeinated coffee consumption on intraocular pressure, ocular perfusion pressure, and ocular pulse amplitude: a randomized controlled trial. Eye (Lond) 2012; 26(8): 1122–1130.
  88. Robertson D, Wade D, Workman R, et al. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 1981; 67(4): 1111–1117.
  89. Clark I, Landolt HP. Coffee, caffeine, and sleep: A systematic review of epidemiological studies and randomized controlled trials. Sleep Med Rev 2017; 31: 70–78.
  90. Lara DR. Caffeine, mental health, and psychiatric disorders. J Alzheimers Dis 2010; 20(Suppl 1): S239–248.
  91. Chen LW, Wu Y, Neelakantan N, et al. Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis. BMC Med 2014; 12: 174.
Labels
General practitioner for children and adolescents General practitioner for adults
The evaluation of mental fitness of elderly to drive motor vehicles: recommendation for general practitioners (GP)
24-hour movement behaviour of families with 3–8-year-old offspring and factors associated with reduced risk of childhood excess body weight
Drug interactions with smoking and nicotine
Selected aspects of safe patient handling
Ethical aspects in gerontology and geriatrics
Fall risk in hospitalized geriatric patients with malnutrition
Liposarcoma of the spermatic cord
Fyzická aktivita a depresivní symptomatologie
Vzpomínka na prof. PhDr. Jana Vymětala
Article was published in

General Practitioner

Issue 5
2023 Issue 5
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#